[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100478643":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":34,"responsibleParty":55,"collaborators":58,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":75,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":82,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"University Hospital, Montpellier","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"neurodevelopmental disorders",null,"Step 1 - Screening: the targeted sample is the siblings of the autistic children, these siblings being at risk of neurodevelopmental disorders.\n\nStep 2 - Clinical interview: All the children with a positive screening.",[13],"Diagnostic Test: Step 1 - Screening ; Step 2 - Clinical interview",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","Step 1 - Screening ; Step 2 - Clinical interview","Step 1: screening is performed by online parental questionnaires (SRS-2, Identidys scale, DCDQ, parental concerns questionnaire ) via a web platform. Parents and registered doctors will be informed by mail in case of negative screening; In case of positive screening, they will be called by phone in order to give them the results and to invite them for a clinical and semi-structured interview.\n\nStep 2: The semi-structured interview will be performed by a psychologist specialized in NDD in order to clinically confirm the results of the screening and refer the child to care and interventions, by mail to the registered doctor. Around 12 months after this interview, parents will be called by phone to collect a description of the referral and their satisfaction about the screening process.",[9],[21],{"name":22,"affiliation":5,"role":23},"Véronique GONNIER, Dr","PRINCIPAL_INVESTIGATOR",[25,31],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"Cécile MICHELON","CONTACT","467330986","+33","c-michelon@chu-montpellier.fr",{"name":32,"role":27,"phone":10,"phoneExt":10,"email":33},"Charlotte GERBE","charlotte.gerbe@chu-montpellier.fr",[35],{"facility":36,"status":37,"city":38,"state":10,"zip":10,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Chu Montpellier","RECRUITING","Montpellier","France","FR",{"type":42,"coordinates":43},"Point",[44,45],3.87635,43.61093,{"lat":45,"lon":44},[48,49,50,52],{"name":26,"role":27,"phone":10,"phoneExt":10,"email":30},{"name":32,"role":27,"phone":10,"phoneExt":10,"email":33},{"name":51,"role":23,"phone":10,"phoneExt":10,"email":10},"Veronique GONNIER, Dr",{"name":53,"role":54,"phone":10,"phoneExt":10,"email":10},"Amaria BAGHDADLI, Prof","SUB_INVESTIGATOR",{"type":23,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Véronique GONNIER","child psychiatrist",[59],{"name":60,"class":61},"Direction Générale de l'Offre de Soins","OTHER_GOV","100478643","screening-for-neurodevelopmental-disorders-in-siblings-of-children-with-autism-diagnosed-in-tertiary-centers-100478643",false,"NCT05512637","Screening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers","FRATSA","Inclusion Criteria:\n\n* Step 1: Brothers or sisters (including stepsisters and brothers); aged between 2 and 16 years; living in Occitanie; informed and express consent of parents ; affiliated to social security.\n* Step 2: step 1 positive screening or parental concerns for child's development ; parental signed informed consent.\n\nExclusion Criteria:\n\n* Parents (or child) refusal to participate; adopted brother or sister. Do not speak French","ALL","2 Years","16 Years",{"count":73,"type":74},384,"ESTIMATED","12 Months","OBSERVATIONAL","In this study, a selective and multi-stages screening for neurodevelopmental disorders (NDD) in siblings of children with a confirmed ASD is done. The main aims are to estimate the prevalence of NDD among siblings and to evaluate the feasibility and acceptability of a standardized screening procedure.",[79,80,81],"Autism Spectrum Disorder","Siblings","Neurodevelopmental Disorders",[80,83,79,81],"Screening","2025-03-25",{"date":86,"type":87},"2025-03-30","ACTUAL",{"date":89,"type":87},"2023-11-28",{"date":91,"type":74},"2026-11",{"name":5,"class":6},1]